Suppression of invasion has also been shown for Cx32 in renal cell carcinoma cells, via a SRC-STAT3-vascular endothelial growth factor (VEGF) pathway [197], and for Cx43 in prostate cancer cells when localized intracellularly [179]. This evidence concerns the gene VEGFA and prostate cancer.